Research awarded St. Baldrick’s Foundation Grant

On May 3rd 2019 Co-founder and Chairman of the Board, Dr. Mads Daugaard, was awarded St. Baldrick’s Foundation Awards One-of-a-Kind Grant to Aid in Childhood Cancer Research Discovery for his work to identify and exploit secondary modifications of proteins as targets for novel experimental immunotherapies.

We are very proud and happy for this appreciation of Dr. Daugaard's great personal acheivements. The award is also an important acknowledgement of the idea of using the unique feature of oncofetal CSA expression as target for new effective cancer therapies, which VAR2 Pharmaceutucals is founded on.

Read more here.